Tumor markers which include CA125, lactate dehydrogenase (LDH), alpha-fetoprotein (AFP), and HCG are essential for malignancy confirmation in perimenopausal women, allowing them to be referred to a tertiary care center for early proper intervention and to decrease patient's morbidity. The gene discussed is AFP; the disease is neoplasm.